Synchronization of plasma exchange and adjuvant treatments

Transfusion Science

Volumn 19, Issue 1, 1998, Pages 27-33

  Guillevin, Loïc ^a  

^a AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE;

ADJUVANT THERAPY; CONFERENCE PAPER; CRYOGLOBULINEMIA; HEPATITIS B; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; PLASMAPHERESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT PLANNING; VASCULITIS;

CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; HUMANS; PLASMA EXCHANGE;

EID: 0347018725     PISSN: 09553886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3886(98)00006-X     Document Type: Conference Paper

References (31)

1. Guillevin L, Tanter Y, Blétry O, et al.: Treatment of severe polyarteritis nodosa with plasma exchange. Progress in Artificial Organs 1983; 723-726.
2. Guillevin L, Lhote F, Jarrousse B, Fain O: Treatment of polyarteritis nodosa and Churg-Strauss syndrome. A metaanalysis of 3 prospective controlled trials including 182 patients over 12 years. Ann Méd Interne (Paris) 1992; 143:405-416.
3. Cohen P, Tri Nguyen Q, Ferrière F, et al.: Treatment of mixed cryoglobulinemia with recombinant interferon-alpha and adjuvant therapies. Ann Méd Interne (Paris) 1996; 147:81-6.
4. Lockwood C, Rees A, Pinching A: Plasma exchanges and immunosuppression in the treatment of fulminating immune complex crescentic nephritis. Lancet 1977; 1:63-7.
5. Euler HH, Guillevin L: Plasmapheresis and subsequent pulse cyclophosphamide in severe systemic lupus erythematosus. An interim report of the Lupus Plasmapheresis Study Group. Ann Méd Interne (Paris) 1994; 145:296-302.
6. Dalakas MC: Current treatment of the inflammatory myopathies. Curr Opin Rheumatol 1994; 6:595-601.
7. Jones J: Plasmapheresis in systemic lupus erythematosus. Clin Rheum Dis 1982; 8:243-260.
8. Schroeder JO, Euler HH: Treatment combining plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus. Adv Exp Med Biol 1989; 260:203-213.
9. Schroeder JO, Euler HH, Loffler H: Synchronization of plasmapheresis and pulse cyclophosphamide in severe systemic lupus erythematosus. Ann Intern Méd 1987; 107:344-346.
10. Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM (The Lupus Nephritis Collaborative Study Group): A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med 1992; 326:1373-1379.
11. Euler HH, Schroeder JO (The Lupus Plasmapheresis Study Group): Plasmapheresis for lupus nephritis (letter). N Engl J Med 1992; 327:1029-1030.
12. Euler HH, Schroeder JO, Harten P, Zeuner RA, Gutschmidt HJ: Treatment-free remission in severe systemic lupus erythematosus following synchronization of plasmapheresis with subsequent pulse cyclophosphamide. Arthritis Rheum 1994; 37:1784-1794.
13. Schroeder JO, Euler HH: Antibody rebound after plasmapheresis: experimental evidence and clinical consequences. Prog Clin Biol Res 1990; 337:415-417.
14. Herrlinger J, Muller-Ruchholtz W: Different suppressive effects of combined cyclophosphamide-antigen treatment compared with exclusive cyclophosphamide treatment on primary and secondary humoral immune reactivity. Int Arch Allergy Appl Immunol 1978; 57:82-89.
15. Dabrow MB, Wilkins JC: Hematologic emergencies. Management of hyperleukocytic syndrome, DIC, and thrombotic thrombocytopenic purpura. Postgrad Med 1993; 93:193-194.
16. Dau PC, Callahan J, Parker R, Golbus J: Immunologic effects of plasmapheresis synchronized with pulse cyclophosphamide in systemic lupus erythematosus. J Rheumatol 1991; 18:270-276.
17. Eaton AM, Serota H, Kernodle GJ, Uglietta JP, Crawford J, Fulkerson WJ: Pulmonary hypertension secondary to serum hyperviscosity in a patient with rheumatoid arthritis. Am J Med 1987; 82:1039-1045.
18. Guillevin L, Lhote F, Cohen P, et al.: Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine Baltimore 1995; 74:238-253.
19. Brouet J, Clauvel J, Danon F, Klein M, Seligman M: Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974; 57:775-788.
20. Agnello V: Mixed cryoglobulinemia and hepatitis C virus. Hosp Pract Off Ed 1995; 30:35-42.
21. Ferri C, Gremignai G, Bombardieri S, et al.: Plasma-exchange in mixed cryoglobulinemia: effects on renal, liver, and neurologic involvement. Ric Clin Lab 1986; 16:403-11.
22. Ferri C, Marzo E, Longombardo G, et al.: Interferon-alpha in mixed cryoglobulinemia patients - a randomized, crossover-controlled trial. Blood 1993; 81:1132-1136.
23. Ghérardi R, Belec L, Mhiri C, et al.: The spectrum of vasculitis in human immunodeficiency virus-infected patients. A clinicopathologic evaluation. Arthritis Rheum 1993; 36:1164-1174.
24. Lebargy F, Branellec A, Deforges L, Bignon J, Bernaudin J: HIV-1 in human alveolar macrophages from infected patients is latent in vivo but replicates after in vitro stimulation. Am J Respir Cell Mol Biol 1994; 10:72-78.
25. Gisselbrecht M, Cohen P, Lortholary O, et al.: HIV-related vasculitis: clinical presentation and therapeutic approach to six patients (letter). AIDS 1997; 11:121-123.
26. French Cooperative group for Plasma Exchange in Guillain-Barré Syndrome: Efficacy of plasma exchange in Guillain-Barré syndrome: role of replacement fluids, Ann Neurol, 1987, 22, 753-761.
27. Van der Meche F: The Guillain-Barré syndrome. Baillières Clin Neurol 1994; 3:73-94.
28. Plasma exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group: Randomized trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997; 349:225-230.
29. Bussel A, Boulechfar H, Naim R: Synchronisation d'épurations plasmatiques et d'immunoglobulines polyvalentes intraveineuses. Ann Méd Interne (Paris) 1993; 144:532-538.
30. Rock G, Shumak K, Buskard M, et al.: Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991; 325:393-397.
31. Henon P: Thrombotic thrombocytopenic purpura: clinical results of a French controlled trial. Transfus Sci 1992; 13:63-72.